It has been demonstrated that somatostatin and its analogs display antiangiogenic and antiproliferative activity on tumor cells both in vitro and in vivo, highlighting that some neuropeptides and specially its synthetic derivatives could be potentially used as antitumor agents. This evidence concerns the gene SST and neoplasm.